Agreement

T2 Biosystems to license pathogen-detection technology
By LabPulse.com staff writers
T2 Biosystems plans to license its proprietary technology for the detection of sepsis-causing pathogens from whole blood.
December 9, 2024
Bacteria Blood Sepsis Social
Labcorp completes lab asset acquisition, names new CFO
By LabPulse.com staff writers
Labcorp has completed its acquisition of the molecular testing site and other assets of an independent clinical laboratory in Birmingham, AL.
November 20, 2024
Agreement Legal Settlement Social
Alveo Technologies to develop avian influenza A(H5) test with CDC
By LabPulse.com staff writers
Under the agreement with the CDC, Alveo Technologies will develop a rapid diagnostic to detect and differentiate between influenza A and B and influenza A/H5, also known as the avian influenza subtype, in humans.
November 14, 2024
Colorized transmission electron micrograph of avian influenza A H5N1 virus particles shown in yellow.
Twist Bioscience enters deal for $15M million cash upfront
By LabPulse.com staff writers
Synthetic biology and genomics company Twist Bioscience has entered a deal with Xoma Royalty Corporation.
October 22, 2024
Businesspeople Decision
Codexis, Alphazyme forge licensing agreement for genomics enzymes
By LabPulse.com staff writers
Enzyme engineering firm Codexis has entered into a commercial and manufacturing license agreement with Alphazyme for multiple enzymes from Codexis' life science enzyme portfolio.
October 3, 2024
Hands Shaking Deal Social
Scancell, PharmaJet sign agreement for melanoma vaccine delivery system
By LabPulse.com staff writers
Clinical-stage biopharmaceutical company Scancell has signed a strategic partnership agreement with PharmaJet for the supply of PharmaJet's needle-free Stratis delivery system for the delivery of Scancell's advanced melanoma vaccine.
September 18, 2024
Business Agreement Social
CDC adds commercial lab contracts for infectious disease, bird flu testing
By Liz Carey
Clinical laboratories incentivized to develop diagnostic tests earlier.
September 17, 2024
Colorized transmission electron micrograph of avian influenza A H5N1 virus particles shown in yellow.
A. Menarini, Nucleix sign distribution agreement for bladder cancer test
By LabPulse.com staff writers
A. Menarini Diagnostics and liquid biopsy firm Nucleix have signed a strategic partnership for the exclusive distribution of Nucleix's Bladder EpiCheck test.
September 9, 2024
Bladder Urinary 3 D Social
Carolina Liquid Chemistries, Medline sign distribution deal for POC fentanyl screening test
By LabPulse.com staff writers
Carolina Liquid Chemistries has forged an agreement with medical supply manufacturer and distributor Medline Industries to distribute its point-of-care fentanyl screening test kit to healthcare providers and clinical laboratories across the U.S.
August 2, 2024
Alcohol Drugs Pills Social
Siga Technologies, HHS sign $113M procurement deal for smallpox, mpox treatment
By LabPulse.com staff writers
Biotech company Siga Technologies announced that the U.S. Department of Health and Human Services (HHS) exercised a procurement option on an existing contract with Siga to deliver approximately $113 million of the firm's oral antiviral treatment TPoxx.
July 22, 2024
3 D Monkeypox Infecting Cell Social
Patient Square Capital to acquire NanoString assets for $220M
By LabPulse.com staff writers
NanoString Technologies has reached a binding agreement with Patient Square Capital in which NanoString will sell substantially all of its assets to the investment firm for $220 million.
March 11, 2024
Business Agreement Social
Flatiron Health, Guardant Health to integrate tests, EMR platform
By LabPulse.com staff writers
Flatiron Health and Guardant Health have signed an agreement to integrate Guardant’s genomic profiling test portfolio into Flatiron’s cloud-based OncoEMR electronic medical record (EMR) platform.
November 1, 2023
Business Agreement Social
Page 1 of 17
Next Page